American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Berger
    Berger
  3. Ladanyi
    Ladanyi
  4. Schram
    Schram
  5. Drilon
    Drilon
  6. Bandlamudi
    Bandlamudi
  7. Stadler
    Stadler
  8. Arcila
    Arcila
  9. Makker
    Makker
  10. Schultz
    Schultz

Groups

  1. Department of Medicine (58)
  2. Early Drug Development Service (58)
  3. Solid Tumor Oncology Division (58)
  4. GSK Faculty (37)
  5. Human Oncology and Pathogenesis Program (34)
  6. Department of Pathology and Laboratory Medicine (28)
  7. Hematology-Oncology Fellows (28)
  8. Genitourinary Oncology Service (25)
  9. Breast Medicine Service (22)
  10. Gynecologic Medicine Service (22)
Search Within
  1. "David Hyman"
Formats
  1. Meeting Abstract (33)
  2. Journal Article (25)
Groups
  1. Department of Medicine (58)
  2. Early Drug Development Service (58)
  3. Solid Tumor Oncology Division (58)
  4. GSK Faculty (37)
  5. Human Oncology and Pathogenesis Program (34)
  6. Department of Pathology and Laboratory Medicine (28)

More Groups

People
  1. David Hyman (58)
  2. David Solit (23)
  3. Michael Berger (20)
  4. Ahmet Zehir (14)
  5. Marc Ladanyi (14)
  6. Alison Schram (13)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2020 (11)
  5. 2019 (21)
  6. 2018 (10)

More Years

Publications
  1. Cancer Research (32)
  2. Clinical Cancer Research (26)

Results (58)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Trastuzumab and pertuzumab in patients with non-breast/gastroesophageal HER2-amplified tumors: Results from the NCI-MATCH ECOG-ACRIN trial (EAY131) subprotocol J
    Journal Article

    Connolly, R. M.; Wang, V.; Hyman, D. M.; Grivas, P.; Mitchell, E. P.; Wright, J. J.; Sharon, E.; Gray, R. J.; McShane, L. M.; Rubinstein, L. V.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Natural history and characteristics of ERBB2-mutated hormone receptor-positive metastatic breast cancer: A multi-institutional retrospective case-control study from AACR Project GENIE
    Journal Article

    LeNoue-Newton, M. L.; Chen, S. C.; Stricker, T.; Hyman, D. M.; Blauvelt, N.; Bedard, P. L.; Meric-Bernstam, F.; Punglia, R. S.; Schrag, D.; Lepisto, E. M.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Phase I basket study of taselisib, an isoform-selective PI3K inhibitor, in patients with PIK3CA-mutant cancers
    Journal Article

    Jhaveri, K.; Chang, M. T.; Juric, D.; Saura, C.; Gambardella, V.; Melnyk, A.; Patel, M. R.; Ribrag, V.; Ma, C. X.; Aljumaily, R.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • The utility of plasma ctDNA for detection of KRAS G12C and other mutations in lung cancers
    Meeting Abstract

    Murciano-Goroff, Y. R.; Arbour, K. C.; Offin, M. D.; Tu, H. Y. Y.; Lebow, E. S.; Shaffer, T. S.; Bertucci, C.; Hosseini, S. A.; Garg, K.; Lim, L. P.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Kinase fusions drive endocrine resistance in estrogen receptor-positive breast cancer
    Meeting Abstract

    Liu, B.; Ross, D. S.; Schram, A. M.; Razavi, P.; Lagana, S. M.; Zhang, Y.; Scaltriti, M.; Bromberg, J. F.; Ladanyi, M.; Hyman, D. M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
    Meeting Abstract

    Cocco, E.; Lee, J. E.; Kannan, S.; Schram, A. M.; Won, H. H.; Shifman, S.; Kulick, A.; Baldino, L.; Toska, E.; Arena, S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Oncologic therapy shapes the fitness landscape of clonal hematopoiesis
    Meeting Abstract

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; Coombs, C.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Capivasertib, an AKT kinase inhibitor, as monotherapy or in combination with fulvestrant in patients with AKT1(E17K)-mutant, ER-positive metastatic breast cancer
    Journal Article

    Smyth, L. M.; Tamura, K.; Oliveira, M.; Ciruelos, E. M.; Mayer, I. A.; Sablin, M. P.; Biganzoli, L.; Ambrose, H. J.; Ashton, J.; Barnicle, A.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Landscape and outcome of TRK fusion-positive cancers
    Meeting Abstract

    Rosen, E. Y.; Goldman, D. A.; Hechtman, J. F.; Benayed, R.; Schram, A. M.; Cocco, E.; Shifman, S.; Gong, Y.; Kundra, R.; Solomon, J. P.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Characterizing KRAS G12C and other mutations in plasma ctDNA from patients with lung cancer
    Meeting Abstract

    Murciano-Goroff, Y. R.; Lebow, E. S.; Tu, H. Y.; Li, M.; Lim, L. P.; Arbour, K. C.; Travis, W.; Solit, D. B.; Ladanyi, M.; Jones, D. R.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: